triaziquone has been researched along with Carcinoma 256, Walker in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asbach, HW; Bersch, W | 1 |
Mattern, J; Volm, M; Wayss, K | 2 |
Faufmann, M; MAttern, J; Volm, M; Wayss, K | 1 |
Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
Wüst, GP | 1 |
Athen, B; Guglielmi, H | 1 |
Schneider, R | 1 |
Teichmann, B | 1 |
9 other study(ies) available for triaziquone and Carcinoma 256, Walker
Article | Year |
---|---|
The effect of in situ isolated perfusion of experimental renal tumors with cytotoxic agents in high concentration.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chemotherapy, Cancer, Regional Perfusion; Drug Therapy, Combination; Kidney Neoplasms; Male; Methotrexate; Neoplasm Transplantation; Rats; Transplantation, Homologous; Triaziquone | 1980 |
[Correlation of in vitro testing and therapeutical results in animal transplanted tumors after cytostatic treatment].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bleomycin; Carcinoma 256, Walker; Cricetinae; Dactinomycin; Doxorubicin; In Vitro Techniques; Male; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma; Podophyllin; Rats; Thymidine; Triaziquone; Uridine | 1975 |
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cricetinae; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; In Vitro Techniques; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma; Procarbazine; Rats; Rats, Inbred ACI; Sarcoma 180; Thymidine; Triaziquone; Uridine | 1975 |
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions].
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cyclophosphamide; Dactinomycin; Daunorubicin; Disease Models, Animal; DNA, Neoplasm; Doxorubicin; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; Hydroxyurea; Male; Methotrexate; Mice; Procarbazine; Rats; RNA, Neoplasm; Time Factors; Triaziquone; Vincristine | 1975 |
[On the question of preclinical selection of cytostatics in the area of treatment of human tumors].
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Culture Techniques; Dactinomycin; Depression, Chemical; DNA, Neoplasm; Fluorouracil; Humans; Lung Neoplasms; Methods; Methotrexate; Neoplasms; Neoplasms, Experimental; Radionuclide Imaging; Rats; RNA, Neoplasm; Stimulation, Chemical; Thymidine; Triaziquone; Tritium; Vinblastine; Vincristine | 1969 |
[Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Benzoates; Carcinoma 256, Walker; DNA, Neoplasm; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Methotrexate; Neoplasm Proteins; Procarbazine; Rats; RNA, Neoplasm; Triaziquone | 1972 |
[Metabolic behavior of tumor slices under the influence of cytostatic compounds].
Topics: Animals; Carbon Isotopes; Carcinoma 256, Walker; Dactinomycin; Depression, Chemical; DNA, Neoplasm; Imidazoles; In Vitro Techniques; Leucine; Mice; Neoplasm Proteins; RNA, Neoplasm; Sulfhydryl Compounds; Thymidine; Triaziquone; Uridine | 1969 |
[Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclopho
Topics: Animals; Carcinoma 256, Walker; Cobalt Isotopes; Cyclophosphamide; Neoplasms, Experimental; Radioisotope Teletherapy; Rats; Sarcoma, Experimental; Sarcoma, Yoshida; Triaziquone | 1965 |
[Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cyclophosphamide; Neoplasm Transplantation; Rats; Triaziquone | 1965 |